Chief Business Officer
Dr. Lawrence Klein
Dr. Lawrence Klein combines significant experience in biotech corporate strategy and business development with an advanced technical background. In his previous role as Vice President of Strategy & Corporate Development at CRISPR, Lawrence led the formation of a number of strategic collaborations and was a key contributor in developing the company’s initial corporate strategy. Before joining our company, Lawrence was an Associate Partner at McKinsey & Company where he was a leader in the biotech practice and served a number of biotechnology companies on a wide range of topics from strategy to operations. Lawrence received a Ph.D. from Stanford University, where he conducted research in the field of T cell immunology and published in several leading scientific journals. He also holds a B.S. from the University of Wisconsin at Madison.